nicotinamide/edema

Diabetes mellitus is a metabolic disease with a growing prevalence worldwide, affecting 171 million people in 2000 and an expected 366 million people in 2030 [1].. Currently available therapies for type 2 diabetes have various limitations and are associated with increased risk of hypoglycemia,

A spontaneous improvement was noted in some patients who were experiencing deteriorating retinal vein occlusions. A chart review and questioning of the patients revealed that the addition of Niacin by the Internist seemed to be the factor that was bringing about the vision improvement. The Niacin

The aim of this study is to develop a less risky, yet effective and more sustainable treatment for retinal vein occlusions than the current commonly used approach of repeated intravitreal triamcinolone acetonide (Kenalog) injections. The types of retinal vein occlusion that are being studied include

STUDY DESIGN This is a randomized controlled clinical trial. Subjects Inclusion criteria: 1. History of acute watery diarrhoea of <72 hrs. 2. Either sex. 3. Age - 6m to 60 months 4. Some or severe dehydration. 5. Wt for Ht <70% of NCHS median: with or without edema. 6. Dark field examination